FDG-PET Scans for Alzheimer’s: How Brain Metabolism Appears on This Scan

On FDG-PET, Alzheimer's appears as dimmed regions where brain cells struggle to consume glucose—a metabolic fingerprint visible years before memory loss.

On FDG-PET, Alzheimer's appears as dimmed regions where brain cells struggle to consume glucose—a metabolic fingerprint visible years before memory loss.

Blood tests can now detect Alzheimer's brain changes years before memory problems appear, rivaling the accuracy of expensive imaging and invasive procedures.

Digital cognitive assessments measure processing speed and attention patterns with millisecond precision, revealing subtle decline that traditional paper tests miss.

New understanding of how brain cells malfunction in Alzheimer's and FTD is opening treatment routes beyond protein cleanup.

FDA-approved Alzheimer's drugs now slow cognitive decline by up to 35%, while new therapies targeting tau and inflammation move through clinical trials.

A memory test at an Alzheimer's appointment measures thinking and recall through standardized cognitive tasks that take 30 minutes to an hour.

Memory tests for Alzheimer's measure recall, attention, and thinking speed to detect early cognitive decline through timed tasks and questions.

In fact, research shows that neuropsychiatric symptoms like anxiety, depression, and irritability often emerge years before cognitive decline becomes...

Memory loss is the first detectable Alzheimer's symptom in most people, but some experience language or behavioral changes first.

Screening detects abnormalities, but not always disease that will cause harm.